The short version
- The Ebola outbreak has expanded to seven provinces, including Sud-Ubangi in western Congo, marking the first confirmed cases outside the eastern epicenter region.
- Government data indicates nearly 7,000 cases and over 3,300 deaths, with the World Health Organization warning the crisis could surpass the historic West Africa outbreak.
- Aid operations face severe obstacles from insecurity and displacement, while clinical trials for a Bundibugyo-specific vaccine are underway in several affected areas.
The Ebola epidemic in the Democratic Republic of Congo has expanded significantly, reaching a seventh province and marking a critical shift in the geographic scope of the crisis. Local authorities confirmed that the virus has spread to Sud-Ubangi, located in the northwestern part of the country. This development is particularly alarming because it represents the first time the outbreak has moved beyond the eastern provinces where cases had previously been concentrated. The expansion suggests that containment measures have not fully halted transmission across long distances within the nation.
The confirmation in Sud-Ubangi stems from testing conducted by Congo’s national research institute, which detected traces of the Bundibugyo virus strain in a sample from the Bulu health district. Jean-Rene Galekwa Vundawe, the governor of Sud-Ubangi, announced the findings on Thursday. While official statements did not disclose detailed information regarding the origin of this specific infection, local lawmaker and former health minister Jean-Jacques Mbungani provided additional context through social media and interviews. He reported that a 23-year-old man tested positive in Gwaka, a town within Sud-Ubangi, before succumbing to the disease on Tuesday.
According to Mbungani, the deceased patient had an extensive travel history that illustrates how easily the virus can move through porous borders and internal transit routes. The man reportedly departed from South Kivu province, where confirmed cases were already present, and traveled internationally to Rwanda and Uganda. He then returned to Congo, moving through Ituri province, which serves as the current epicenter of the outbreak. From there, he traversed Tshopo and Mongala provinces before arriving in Sud-Ubangi. This journey highlights the challenges of tracking contacts in a region characterized by high population mobility.
Medical professionals in Sud-Ubangi were alerted to the patient after he exhibited severe symptoms, including fever and vomiting blood. Samples were collected post-mortem and sent for analysis, leading to the positive identification of the virus. Mbungani expressed deep concern about the potential for further regional spread, noting that Sud-Ubangi shares borders with Congo-Brazzaville and the Central African Republic. The proximity to these neighboring countries raises the risk that the outbreak could cross international boundaries, complicating containment efforts on a continental scale.
As of Wednesday, government figures reported 6,942 confirmed cases and 3,349 deaths nationwide. These numbers reflect a rapidly escalating situation that shows no immediate signs of slowing down. The World Health Organization has stated that the outbreak remains out of control and is on track to become the deadliest in history, potentially surpassing the 2014-2016 West Africa epidemic that killed more than 11,000 people. Although case numbers have declined recently in Ituri province, they have risen sharply in neighboring North Kivu and Haut-Uele, indicating a shifting pattern of transmission.
Efforts to combat the virus are hampered by extremely difficult conditions on the ground. Insecurity, widespread displacement, and a strike by health workers have severely disrupted aid operations. The situation is especially precarious at displacement sites, where residents live in crowded conditions with limited access to healthcare services. These factors create an environment conducive to rapid viral spread and make it difficult for responders to implement effective contact tracing and isolation protocols.
In response to the crisis, Congo began vaccinating health workers and other frontline personnel last month using the Ervebo vaccine. This vaccine has proven effective against the Zaire strain of Ebola, which is more common than the Bundibugyo strain currently driving this outbreak. However, its efficacy against the specific virus variant in question remains uncertain. To address this gap, clinical trials are underway to develop a licensed vaccine specifically for the Bundibugyo virus. Placide Mbala Kingebeni, director of research at Africa CDC, noted that these trials have started in Tshopo, Haut-Uele, and Bas-Uele provinces, with vaccinations in Ituri scheduled to begin next week.
The broader regional context adds urgency to the situation. Neighboring Uganda, which reported 20 cases since May, declared itself free of Ebola in July. However, the World Health Organization has warned that there is a significant risk of spread from Congo to the Central African Republic and South Sudan, both of which border affected provinces. The detection of cases in western Congo underscores the vulnerability of the entire region and highlights the need for coordinated international response efforts to prevent further escalation.
Sources behind this briefing
Go to the original reporting
- PBS NewsHour↗Ebola outbreak in Congo spreads to a 7th province
